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A novel soft way of hyaluronate (HyA) based magnetic hydrogel preparation was revealed. Magnetite
nanoparticles (MNPs) were prepared by co-precipitation. Since the naked MNPs cannot be dispersed
homogenously in HyA-gel, their surface was modiﬁed with natural and biocompatible chondroitin-sul-
fate-A (CSA) to obtain CSA-coated MNPs (CSA@MNPs). The aggregation state of MNPs and that loaded
with increasing amount of CSA up to 1 mmol/g was measured by dynamic light scattering at pH6. Only
CSA@MNP with Z0.2 mmol/g CSA content was suitable for magnetic HyA-gel preparation. Rheological
studies showed that the presence of CSA@MNP with up to 2 g/L did not affect the hydrogel's rheological
behavior signiﬁcantly. The results suggest that the HyA-based magnetic hydrogels may be promising
formulations for future biomedical applications, e.g. as intra-articular injections in the treatment of os-
teoarthritis.
& 2014 Elsevier B.V. All rights reserved.1. Introduction
Hydrogels are in the focus of scientiﬁc interest because of their
tuneable mechanical, chemical and biocompatible properties [1,2].
These materials have been widely used in tissue engineering and
drug-delivery [1,3–5]. Magnetic hydrogels have also been pro-
duced by ﬁlling hydrogels with magnetic particles (e.g. maghe-
mite, magnetite, cobalt-ferrite) [1], this procedure makes them
more suitable for certain biomedical applications, such as drug-
delivery [1,6,7], enzyme immobilization [1,8–10] or cancer therapy
by the combination of controlled drug release and magnetic hy-
perthermia [1,11]. Magnetic hydrogels have been prepared by
three, fundamentally different methods: blending, in situ pre-
cipitation and grafting-onto methods [1]. Innumerable magnetic
hydrogels have been synthesized, e.g. superparamagnetic magne-
tite nanoparticles (MNPs) in kappa-carrageenan nanospheres [12],
in situ synthesized MNPs in chitosan hydrogel [13] and magnetic
hydrogel of chitosan and MNPs for a potential cancer treatment
[14]. Some hyaluronate (HyA) based magnetic hydrogels have been
also prepared, e.g. hybrid magnetic hydrogels for controlled drug-
delivery prepared from (3-aminopropyl)trimethoxysilane-func-
tionalized magnetite or cobalt-ferrite bound chemically to HyA by
N-hydroxysuccinimide and N-(3-dimethylaminopropyl)-N-ethyl-
carbodiimidehydrochloride [15]. Injectable in situ forming hydro-
gel has been synthesized from oleic acid-coated iron oxideI.Y. Tóth),nanoparticles dispersed in toluene and hyaluronic acid modiﬁed
with hydrazide and thiol groups (HA-hy-SH) for MRI contrast
agent [16]. The giant HyA molecules ﬂocculate MNPs and loose
aggregates are formed, which can be prevented only by the pre-
modiﬁcation of either the MNP's surface [15,17] or the chemical
structure of HyA [18] or by the combination of the previous two
[16,19]. Usually harmful chemicals were used during these pre-
parations. In our laboratory, several types of core-shell magnetite
nanoparticles have been produced [20–22] in the absence of risky
chemicals by using poly(acrylic acid) (PAA) [23], poly(acrylic acid-
co-maleic acid) (PAM) [24] and chondroitin-sulfate-A (CSA) [25] as
coating agents to modify the MNP surface.
The osteoarthritis (also called degenerative joint disease) is a
common form of arthritis, which causes health problems for mil-
lions of people [26]. There are many reasons potentially re-
sponsible for the osteoarthritis, such as genetic factors, increased
stress (i.e., hard physical work, sport, overweight) and decreased
viscoelasticity of the intra-articular ﬂuid. The latter can be caused
by the reduced amount of hyaluronate (HyA) in the synovial ﬂuid
[27]. The supplement of synovial ﬂuid by hyaluronate-containing
intra-articular injection is a common treatment for osteoarthritis
[26–30]. The typical composition of these gels (for example
Hyalgan, Ostenil-Tendon, SportVis, Synvisc, Synocrom) is an iso-
tonic solution (150 mM NaCl, pH 7.3 adjusted by buffer) con-
taining 1% of sodium hyaluronate. There are several problems with
this treatment, for example the rapid enzymatic degradation of
HyAwithin the joints [31], the pain and the risk of infection during
the injection procedure. Furthermore, during movement and un-
der the weight of the patient's body, the synovial ﬂuid could be
Fig. 1. The repeating units of (a) chondroitin-sulfate-A (CSA) and (b) hyaluronic acid (HyA) [41].
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articular treatments. Our approach is to overcome the latter defect
by using magnetic hydrogel and its ﬂowability that can be regu-
lated by an implanted permanent magnet.
The aim of our research was to prepare HyA-based magnetic
hydrogel samples in a soft way using biocompatible chemicals,
which may be potentially used as an intra-articular injection in the
future. The chemical structures of hyaluronate and biocompatible
chondroitin-sulfate-A are very similar (Fig. 1), so it is presumable
that the surface of CSA-coated superparamagnetic magnetite na-
noparticles (CSA@MNPs) is compatible with the HyA-gel. We in-
tend to prepare stable MNPs and CSA-coated MNPs, and to test
their stability and aggregation in dilute HyA-gels. Finally, we plan
to prepare HyA-based magnetic hydrogels and to test the effect of
increasing CSA@MNP concentration on the rheological properties.2. Materials and methods
2.1. Materials
The magnetite was prepared by co-precipitation [32–36]. The
FeCl2, FeCl3 and NaOH for magnetite synthesis were analytical
grade reagents obtained from Molar, Hungary. The precipitate was
puriﬁed carefully through washing and dialysis. It was stored at
pH3 and 4 °C as stable sol. The resulting iron-oxide was identi-
ﬁed as magnetite, based on the characteristic black color, strong
magnetism and the X-ray diffraction pattern (JCPDS database [37]).
The mean diameter of the MNPs, determined by Scherrer equation
and transmission electron microscopy, was 10 nm [21].
The chondroitin-sulfate-A (CSA) was purchased from Sigma-
Aldrich as sodium-salt, and the sodium-salt of hyaluronic acid
(HyA) was kindly provided by the Department of Pharmaceutical
Technology (University of Szeged, Hungary). One repeating unit of
CSA (M¼503 Da) contains one –COOH and one –SO3H group
(Fig. 1a) and that of HyA (M¼379 Da) contains one –COOH group
(Fig. 1b). The strongly acidic sulfate groups (– −SO3) in CSA are fully
deprotonated at a wide pH-range [38,39]. However, the –COOH
groups in CSA and HyA have pH-dependent dissociation
(pKβ-glucuronic acid 2.9) [40] but, even so, these groups are fully
deprotonated (–COO–) at pH 6.3 applied in our experiments. The
notations “CSA” and “HyA” are used in this article for sodium-salt
regardless of the actual degree of dissociation of the carboxylic
groups. The amount of CSA and HyA is expressed through the mole
of repeating units, which equals to the number of dissociable –
COOH groups.
The CSA-coated magnetite nanoparticles (CSA@MNPs) were
prepared at pH¼6.370.3 and 10 mM NaCl, the MNP-content was
20 g/L, the CSA-loading was 0.2, 0.4 and 1.0 mmol –COOH/g MNP
and the adsorption time was one day. These amounts of CSA
completely coat MNPs and provide the high colloidal stability of
the CSA@MNP particles [25].The HyA-gel was prepared by the dissolution of hyaluronic acid
in ultra pure water under one day long continuous stirring. The
HyA-content of the stock-gel was 11 mg/mL and the pH was 5.8.
Thereafter, the calculated amounts of the naked MNPs or
CSA@MNPs at 0.4 mmol/g CSA-loading were added to 9 mL of the
previously prepared HyA-gel under vigorous magnetic stirring and
the total volume was adjusted to 10 mL using 10 mM NaCl solu-
tions (pH¼6.370.3). Stirring was continued for ﬁve minutes. The
ﬁnal HyA-content of the hydrogels was 10 mg/mL similar to that in
commercial HyA-based intra-articular injections (for example Sy-
nocrom). The magnetite-content of the magnetic hydrogels was
2.0 g/L for the naked MNPs and 0.0, 0.2 and 2.0 g/L for CSA@MNPs
at pH 6.0 and 1 mM NaCl. The HyA-gels were stored in closed
vials at 4 °C.
NaCl, HCl and NaOH, analytical grade products of Molar
(Hungary), were used to adjust the pH and salt concentration in all
experiments. Ultra pure water from a Milli-Q RG water puriﬁcation
system (Millipore) was used. All measurements were performed at
2570.1 °C.2.2. Particle size determination
For characterization of the aggregation state of magnetic na-
noparticles in diluted HyA-systems, the Z average particle hydro-
dynamic diameter of bare magnetite and of CSA-coated nano-
particles was determined at 2570.1 °C using dynamic light scat-
tering (DLS) method, an apparatus Nano ZS (Malvern) with a
4 mW HeNe laser source (λ¼633 nm) operating in back-
scattering mode at an angle of 173°. The dispersions contained
100 mg/L of magnetite to get an optimal intensity of 105 counts
per second. Prior to the measurements, the samples were homo-
genized in an ultrasonic bath for 10 s, after which 2 min relaxation
was allowed. For evaluation, second- or third-order cumulant ﬁt of
the autocorrelation functions was used, depending on the degree
of polydispersity. The inﬂuence of the added HyA amounts (0.0–
2.5 mmol HyA/g magnetite) was determined at pH¼6.370.3 and
10 mM NaCl in case of MNPs and CSA@MNPs. The CSA-loadings
were 0.2, 0.4, and 1.0 mmol CSA/g magnetite [25].2.3. Electrokinetic potential measurements
Electrophoretic mobilities of the naked magnetite and
CSA@MNP dispersions were measured at 2570.1 °C in a Nano ZS
(Malvern) apparatus using disposable zeta cells (DTS 1060). The
zeta-standard of Malvern (5575 mV) was used for calibration.
The Smoluchowski equation was applied to convert electro-
phoretic mobilities to electrokinetic potential values. The accuracy
of the measurements was 75 mV. The samples were identical to
those in the DLS experiments.
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The ﬂow properties of the prepared blank HyA- and magnetic
HyA-gels (Section 2.1.) were characterized systematically. The
rheological measurements of three-days old samples were carried
out with a Physica MCR101 rheometer (Anton Paar, Austria) and a
plate-plate measuring device (diameter: 5 cm) at 2570.1 °C.
Flow curves of the different samples were determined. The
shear rate was increased from 0.5 to 50 s1 (upward curve), and
then it was decreased from 50 to 0.5 s1 (downward curve) in the
CR mode. The shearing time in both segments was 60 s. The
downward curves over the plastic ﬂow range (above shear rate
20 s1) were evaluated according to the Bingham-model given
by Eq. (1)
τ τ η γ= + d dt/ (1)B pl
where τ is the shear stress, τB is the Bingham yield value, ηpl the
plastic viscosity and dγ/dt the shear rate [42,43].
The creep tests were performed to determine the viscoelastic
behavior under static condition. A constant stress (0.1 and 5.0 Pa)
was applied for 60 s and the resulting deformation was measured
(creep), then stress was released and the deformation was mea-
sured again for 60 s (recovery).
The dynamic tests of viscoelasticity were also conducted in
forced oscillation measurements in the range of stress from 0.1 to
10 Pa at 1 Hz and of frequency from 0.1 to 10 Hz at 1 Pa. Both
storage modulus (G′) and loss modulus (G″) were analyzed.Fig. 3. Effect of increasing HyA-addition (up to 2.5 mmol/g, see the numbers on the
vials) on the colloidal stability of the naked MNP and CSA@MNP (CSA-loading:
0.4 mmol/g) dispersions after standing for 24 h at pH6.3 and 10 mM NaCl, at a
solid/liquid ratio of 100 mg/L.3. Results and discussion
3.1. Electrokinetic potential, particle size and aggregation
The changes in the Z average particle diameter and the elec-
trokinetic potential of the naked and CSA-coated magnetite na-
noparticles are plotted as a function of HyA-addition in Fig. 2.
Photos in Fig. 3 show the change in colloidal stability of MNP and
CSA@MNP at 0.4 mmol/g CSA-loading as a function of HyA-addi-
tion after standing for one day.
With increasing HyA-concentration, the aggregation state of
the originally naked MNPs changes characteristically (see Fig. 3).
At pH6.3 and 10 mM NaCl, the naked magnetite is aggregated
and settled [23,24]. Although the net surface charge of MNP is
positive due to the presence of ≡Fe–OH2þ groups on the surface
[23,24,32,33,37,44–46], the amount of the charge is not enough toa
Fig. 2. Effect of HyA-addition on the (a) Z average particle diameter and (b) electrokin
pH6.3 and 10 mM NaCl, at a solid/liquid ratio of 100 mg/L. (Lines are drawn as guid
repeating units given in mmol.).stabilize the particles electrostatically. The electrokinetic potential
of the naked magnetite is þ25 mV, and this sample is ag-
gregated (1000 nm) (see Fig. 2). In case of trace (o0.5 mmol/g)
or very large (41.5 mmol/g) amounts of HyA, the particles settle
after 24 h. However, at intermediate HyA-concentrations (0.5–
1.5 mmol/g) the magnetite dispersions are stable (middle samples
in Fig. 3). The electrokinetic potential of the positive naked MNPs
declines with the increase in the amount of added HyA because
the negatively charged HyA adsorbed on MNPs. The charge neu-
tralization occurs at 0.05 mmol/g HyA-addition, resulting in
surface charge heterogeneity due to the patch-wise adsorption of
HyA. This marks the isoelectric point (IEP) and the size of
HyA@MNP aggregates reaches maximum (2300 nm). Further
addition of HyA caused charge reversal and reduced the electro-
kinetic potential to 40 mV. The electrosteric stabilization, ty-
pical for polyelectrolytes, can be observed only in the range of
0.5–1.5 mmol/g HyA. Stabilization is accompanied by a low hy-
drodynamic diameter (250 nm). The aggregation observed at
larger HyA-addition (41.5 mmol/g) is caused by the ﬂocculation
effect of the high molecular weight HyA, so these particles do not
seem to be suitable for preparation of magnetic HyA-gels.
The colloidal state of the originally stable CSA@MNPs [25] does
not change with increasing HyA-concentration (Fig. 3). The
hydrodynamic diameters (150 nm) and the electrokineticb
etic potential of MNPs and CSA@MNPs (CSA-loadings: 0.2, 0.4 and 1.0 mmol/g) at
es for the eye. The amounts of CSA and HyA are expressed as molar amounts of
Fig. 5. Effect of CSA@MNP-content on ﬂow curves of HyA-gels (HyA-content:
10 mg/mL, CSA-loading: 0.4 mmol/g, pH6.0, 1 mM NaCl, 25 °C). (The upward and
downward curves are identical. The lines of ﬁtted Bingham model are marked.).
Table 1
Summary of the hydrogel's characteristic rheological parameters at different
CSA@MNP contents (HyA-content: 10 mg/mL, CSA-loading: 0.4 mmol/g, pH6.0,
1 mM NaCl, 25 °C).
CSA@MNP magnetite content 0.0 g/L 0.2 g/L 2.0 g/L
Bingham yield stress (Pa) 28.0 27.1 30.5
plastic viscosity (Pa s) 0.42 0.42 0.46
crossover point (Hz)a 1.3 1.1 1.4
a Intersection point between the viscous and the elastic behavior in forced
oscillation during the frequency sweep at 1 Pa.
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and the HyA-addition (Fig. 2). Thus, the CSA@MNP particles can be
used to prepare magnetic HyA-gels.
3.2. Rheological measurements of hydrogels
The photos of the HyA-hydrogels prepared at 10 mg/mL HyA
-concentration are shown in Fig. 4. As it was expectable from the
DLS measurements of the diluted gels (Section 3.1.), the naked
MNPs cannot be dispersed homogeneously in the HyA-gel; how-
ever, the CSA@MNP particles are compatible with the hydrogels
forming well dispersed systems. The CSA@MNP-containing mag-
netic hydrogels remained stable and homogeneously dispersed
even after three months of storage.
The ﬂow curves of the HyA-hydrogels at various CSA@MNP-
contents are shown in Fig. 5. There is no signiﬁcant change in the
ﬂow character of gels with increasing CSA@MNP-loading. The
upward and downward curves are identical. Thixotropy is not
detected under the conditions of measurements. The downward
curves were evaluated according to the Bingham-model (Fig. 5).
The Bingham yield values (τB) and the plastic viscosities (ηpl) of all
gels (Table 1) coincide within the error of the measurements. This
is in good agreement with the expected tendency based on the
Einstein-equation [47], since the volume fraction of magnetite
particles is extremly low in these hydrogels (Фr0.004).
The viscoelastic properties of gels can be studied under static
conditions by creep tests. The measured data of the HyA-gels at
different CSA@MNP contents are shown in Fig. 6 at two yield stress
values (0.1 and 5.0 Pa). Both the HyA-gel and the magnetic hy-
drogels show viscous properties at the applied stress values
showing that the extent of deformation depends on the applied
stress, but it is independent of the magnetite content.
The forced oscillation measurements are suitable to study the
viscoelastic properties of gels under dynamic conditions. The os-
cillation tests of the HyA-gels at different CSA@MNP-contents
(Fig. 7) show that all the measured parameters are independent
from the CSA@MNP-content within the error of the measurements.
During the oscillation measurements at 1 Hz (Fig. 7a) the loss
modulus (G″) curves of gels are above the storage modulus (G′)
curves in the whole range of stress (0.1–100 Pa). Thus, under the
condition of measurements the hydrogels show viscous properties.
However, during frequency sweep measurements at 1 Pa (Fig. 7b),
the viscous loss modulus (G″) and the elastic storage modulus (G′)
of gels cross each other. This is characteristic for the viscoelastic
nature of HyA, i.e., at lower frequencies (analogous to the static
position of the body) the HyA-gel behaves as a viscous solution
ensuring to hold the skeleton, however, at higher frequencies
(analogous to the motion of the joints) the hydrogel behavesFig. 4. HyA-gels with MNP and CSA@MNP at different magnetite contents (see on
the vials) (HyA-content: 10 mg/mL, CSA-loading: 0.4 mmol/g, pH6.0, 1 mM NaCl).elastically allowing an effective lubrication between the cartilages
[48–50]. This property is fundamental and essential for the natural
synovial ﬂuid. The transition from viscous to elastic behavior can
be characterized by the so-called crossover point (Table 1), which
is at 1.3 Hz for our magnetic HyA-gels in case of 1 Pa shear
stress.
The characteristic rheological parameters of the magnetic HyA-
gel loaded with 2 g/L CSA@MNP (indicated as HyAþmagnetite‒
COO) can be compared with those of other HyA-based magnetic
hydrogels as shown in Table 2. It can be seen that the values of the
different parameters for the listed hydrogels vary signiﬁcantly,
probably because these measurements were made under different
conditions, such as temperature, salt concentration, pH, ﬁxedFig. 6. Creep and recovery test results for HyA-gels at different CSA@MNP-content
(HyA-content: 10 mg/mL, CSA-loading: 0.4 mmol/g, pH6.0, 1 mM NaCl, 25 °C).
a b
Fig. 7. Forced oscillation tests of HyA-gels at different CSA@MNP-content as a function (a) of shear stress at 1 Hz and (b) of frequency at 1 Pa. (HyA-content: 10 mg/mL, CSA-
loading: 0.4 mmol/g, pH6.0, 1 mM NaCl, 25 °C).
Table 2
Characteristic rheological parameters of different HyA-hydrogels.
Hydrogels magnetic cross-linked at linear range of stress sweep at crossover point in frequency sweep from ﬂow curve
G′ (Pa) G″ (Pa) f (Hz) G′¼G″ (Pa) τB (Pa) ηpl (Pa s)
HyAþmagnetite‒COO a yes no 11 13 1.4 15 30 0.4
HyA þmagnetite‒NH2 [15] b yes yes 350 25 – – – –
HyA-SHþ iron-oxide‒COOH [16] c yes yes 510 – – – – –
HyA [50] no no – – 0.02 20 120 0.7
HyA [50] no yes – – 0.11 20 90 0.7
HyASynvisc [51] d no yes 100 20 – – – –
a Magnetite: chondroitin-sulfate-A-coated.
b Magnetite: 3-aminopropyl)trimethoxysilane-functionalized.
c HyA: modiﬁed with hydrazide and thiol groups, iron-oxide: oleic acid coated in toluene.
d Commercially available intra-articular injection.
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cross-linking. Our magnetic hydrogels are not yet cross-linked,
however, the un-bound carboxylate groups of both CSA and HyA
(as seen in Fig.1) are prone to react with Ca2þ ions forming a cross-
linked structure with tuneable ﬂow properties. The latter will be
the subject of our future studies.4. Conclusions
The aim of this work was to prepare novel biocompatible HyA-
based magnetic hydrogels using CSA-coated superparamagnetic
magnetite nanoparticles and to characterize their aggregation
state and rheological properties as well. The solid experimental
facts allow us to conclude that HyA-based magnetic hydrogels can
be prepared from CSA@MNPs and they remained stable and
homogeneously dispersed even after three month of storage.
Rheological studies show, that at pH6.0 and 1 mM NaCl the
behavior of magnetic hydrogels was appreciably independent from
the magnetite content up to 2 g/L. Further studies are needed at
pH 7.3, 150 mM NaCl and 37 °C to approximate the composition
of commercial HyA-based intra-articular injections and in vivo
conditions. However, the prepared HyA-based magnetic hydrogels
are promising candidates for magnetic intra-articular ﬂuid in the
treatment of osteoarthritis. By implanting a permanent magnet
into the bone in close vicinity of the knee joint for example, themagnetic HyA-gel with increased CSA@MNP content probably can
be held at the eroded area. Thus, it is predictable that the neces-
sary distance between the cartilages can be provided to reduce the
pain during motion and even the requested lubrication can be
ensured in the joint for a longer time.Acknowledgments
This research was supported by the OTKA (NK 84014) Grant as
well as by European Union and the State of Hungary, co-ﬁnanced
in the framework of TÁMOP 4.2.4. A/2-11-1-2012-0001‘National
Excellence Program’. We thank Erzsébet Csányi (University of
Szeged, Department of Pharmaceutical Technology) for rheology
measurements.References
[1] Y. Li, G. Huang, X. Zhang, B. Li, Y. Chen, T. Lu, T.J. Lu, F. Xu, Magnetic hydrogels
and their potential biomedical applications, Adv. Funct. Mater. 23 (2013)
660–672.
[2] N.A. Peppas, P. Bures, W. Leobandung, H. Ichikawa, Hydrogels in pharmaceu-
tical formulations, Eur. J. Pharm. Biopharm. 50 (2000) 27–46.
[3] D. Gao, H. Xu, M.A. Philbert, R. Kopelman, Bioeliminable nanohydrogels for
drug delivery, Nano Lett. 8 (2008) 3320–3324.
I.Y. Tóth et al. / Journal of Magnetism and Magnetic Materials 380 (2015) 175–180180[4] G.D. Nicodemus, S.J. Bryant, Cell encapsulation in biodegradable hydrogels for
tissue engineering applications, Tissue Eng., Part B 14 (2008) 149–165.
[5] S. Ladet, L. David, A. Domard, Multi-membrane hydrogels, Nature 452 (2008)
76–79.
[6] J. Kost, J. Wolfrum, R. Langer, Magnetically enhanced insulin release in diabetic
rats, J. Biomed. Mater. Res. 21 (1987) 1367–1373.
[7] V.M. De Paoli, S.H. De Paoli Lacerda, L. Spinu, B. Ingber, Z. Rosenzweig,
N. Rosenzweig, Effect of an oscillating magnetic ﬁeld on the release properties
of magnetic collagen gels, Langmuir 22 (2006) 5894–5899.
[8] M. Arruebo, R. Fernández-Pacheco, M.R. Ibarra, J. Santamaría, Magnetic na-
noparticles for drug delivery, Nano Today 2 (2007) 22–32.
[9] M.H. Liao, D.H. Chen, Immobilization of yeast alcohol deshydrogenase on
magnetic nanoparticles, Biotechnol. Lett. 23 (2001) 1723–1727.
[10] G. Bayramoglu, B. Altintas, M.Y. Arica, Immobilization of glucoamylase onto
polyaniline-grafted magnetic hydrogel via adsorption and adsorption/cross-
linking, Appl. Microbiol. Biotechnol. 97 (2013) 1149–1159.
[11] L.L. Lao, R.V. Ramanujan, Magnetic and hydrogel composite materials for hy-
perthermia applications, J. Mater. Sci.: Mater. Med 15 (2004) 1061–1064.
[12] A.L. Daniel-da-Silva, S. Fateixa, A.J. Guiomar, B.F. Costa, N.J. Silva, T. Trindade, B.
J. Goodfellow, A.M. Gil, Biofunctionalized magnetic hydrogel nanospheres of
magnetite and kappa-carrageenan, Nanotechnology 20 (2009) 355602.
[13] Y. Wang, B. Li, Y. Zhou, D. Jia, In situ mineralization of magnetite nanoparticles
in chitosan hydrogel, Nanoscale Res. Lett. 4 (2009) 1041–1046.
[14] D. Zhang, P. Sun, P. Li, A. Xue, X. Zhang, H. Zhang, X. Jin, A magnetic chitosan
hydrogel for sustained and prolonged delivery of Bacillus Calmette-Guérin in
the treatment of bladder cancer, Biomaterials 34 (2013) (10258e10266).
[15] R. Barbucci, G. Giani, S. Fedi, S. Bottari, M. Casolaro, Biohydrogels with mag-
netic nanoparticles as crosslinker: characteristics and potential use for con-
trolled antitumor drug-delivery, Acta Biomater. 8 (2012) 4244–4252.
[16] Y. Zhang, Y. Sun, X. Yang, J. Hilborn, A. Heerschap, D.A. Ossipov, Injectable
in situ forming hybrid iron oxide-hyaluronic acid hydrogel for magnetic re-
sonance imaging and drug delivery, Macromol. Biosci. 14 (2014) 1249–1259.
[17] J. Li, Y. He, W. Sun, Y. Luo, H. Cai, Y. Pan, M. Shen, J. Xia, X. Shi, Hyaluronic acid-
modiﬁed hydrothermally synthesized iron oxide nanoparticles for targeted
tumor MR imaging, Biomaterials 35 (2014) 3666–3677.
[18] M. Babic, D. Horak, P. Jendelova, V. Herynek, V. Proks, V. Vanecek, P. Lesn,
E. Sykova, The use of dopamine-hyaluronate associatecoated maghemite na-
noparticles to label cells, Int. J. Nanomed. 7 (2012) 1461–1474.
[19] Y. Lee, H. Lee, Y.B. Kim, J. Kim, T. Hyeon, H. Park, P.B. Messersmith, T.G. Park,
Bioinspired surface immobilization of hyaluronic acid on monodisperse
magnetite nanocrystals for targeted cancer imaging, Adv. Mater. 20 (2008)
4154–4157.
[20] E. Tombácz, I.Y. Tóth, D. Nesztor, E. Illés, A. Hajdú, M. Szekeres, L. Vékás, Ad-
sorption of organic acids on magnetite nanoparticles, pH-dependent colloidal
stability and salt tolerance, Coll. Surf. A 435 (2013) 91–96.
[21] M. Szekeres, I.Y. Tóth, E. Illés, A. Hajdú, I. Zupkó, K. Farkas, G. Oszlánczi,
L. Tiszlavicz, E. Tombácz, Chemical and colloidal stability of carboxylated core–
shell magnetite nanoparticles designed for biomedical applications, Int. J. Mol.
Sci. 14 (2013) 14550–14574.
[22] E. Tombácz, M. Szekeres, A. Hajdú, I.Y. Tóth, R.A. Bauer, D. Nesztor, E. Illés,
I. Zupkó, L. Vékás, Colloidal stability of carboxylated iron oxide nanomagnets
for biomedical use, Period. Polytech-Chem. 58 (2014) 3–10.
[23] A. Hajdú, M. Szekeres, I.Y. Tóth, R.A. Bauer, J. Mihály, I. Zupkó, E. Tombácz,
Enhanced stability of polyacrylate-coated magnetite nanoparticles in bior-
elevant media, Coll. Surf. B 94 (2012) 242–249.
[24] I.Y. Tóth, E. Illés, R.A. Bauer, D. Nesztor, M. Szekeres, I. Zupkó, E. Tombácz,
Designed polyelectrolyte shell on magnetite nanocore for dilution-resistant
biocompatible magnetic ﬂuids, Langmuir 28 (2012) 16638–16646.
[25] I.Y. Tóth, E. Illés, M. Szekeres, E. Tombácz, Preparation and characterization of
chondroitin‐sulfate‐A‐coated magnetite nanoparticles for biomedical appli-
cations, J. Magn. Magn. Mater. accepted for publication.
[26] D.H. Neustadt, Intra-articular injections for osteoarthritis of the knee, Clev.
Clin. J. Med. 73 (2006) 897–911.
[27] C. Carulli, F. Matassi, R. Civinini, M. Morﬁni, M. Tani, M. Innocenti, Intra-ar-
ticular injections of hyaluronic acid induce positive clinical effects in knees of
patients affected by haemophilic arthropathy, Knee 20 (2013) 36–39.[28] O. Namiki, H. Toyoshima, N. Morisaki, Therapeutic effect of intra-articular
injection of high molecular weight híaluronic acid on osteoarthritis of the
knee, Int. J. Clin. Pharmacol. Ther. Toxicol. 20 (1982) 501–507.
[29] K.D. Brandt, G.N. Smith, L.S. Simon, Intraarticular injection of hyaluronan as
treatement, Arthritis Rheum. 43 (2000) 1192–1203.
[30] J.O. Printz, J.J. Lee, M. Knesek, A.G. Urquhart, Conﬂict of Interest in the as-
sessment of hyaluronic acid injections for osteoarthritis of the knee: an up-
dated systematic review, J. Arthroplasty 28 (2013) 30–33.
[31] J. Schiller, N. Volpi, E. Hrabárová, L. Soltés, Hyaluronic acid: a natural biopo-
lymer, in: S. Kalia, L. Avérous (Eds.), Biopolymers: biomedical and environ-
mental applications, John Wiley & Sons, Hoboken, NJ, USA, 2011.
[32] E. Illés, E. Tombácz, The role of variable surface charge and surface com-
plexation in the adsorption of humic acid on magnetite, Coll. Surf. A 230
(2006) 99–109.
[33] E. Illés, E. Tombácz, The effect of humic acid adsorption on pH-dependent
surface charging and aggregation of magnetite nanoparticles, J. Colloid Inter-
face Sci. 295 (2006) 115–123.
[34] L. Vékás, D. Bica, O. Marinica, Magnetic nanoﬂuids stabilized with various
chain length surfactants, Rom. Rep. Phys. 58 (2006) 217–228.
[35] D. Bica, L. Vékás, M.V. Avdeev, O. Marinica, V. Socoliuc, M. Balasoiu, V.
M. Garamus, Sterically stabilized water based magnetic ﬂuids: Synthesis,
structure and properties, J. Magn. Magn. Mater. 311 (2007) 17–21.
[36] E. Tombácz, E. Illés, A. Majzik, A. Hajdú, N. Rideg, M. Szekeres, Ageing in the
inorganic nanoworld: example of magnetite nanoparticles in aqueous med-
ium, Croat. Chem. Acta 80 (2007) 503–515.
[37] R.M. Cornell, U. Schwertmann, The Iron Oxides, Structure, Properties, Reac-
tions, Occurrence and Uses, VCH, Weinheim, 1996.
[38] M. Bathe, G.C. Rutledge, A.J. Grodzinsky, B. Tidor, A. Coarse-Grained, Molecular
model for glycosaminoglycans: application to chondroitin, chondroitin sulfate,
and hyaluronic acid, Biophys. J. 88 (2005) 3870–3887.
[39] R.L. Cleland, Electrophoretic mobility of wormlike chains. I. Experiment:
hyaluronate and chondroitin 4-sulfate, Macromolecules 24 (2010) 4386–4390.
[40] H. Wang, D. Loganathan, R.J. Linhardt, Determination of the pKa of glucuronic
acid and the carboxy groups of heparin by 13C-nuclear-magnetic-resonance
spectroscopy, Biochem. J. 278 (1991) 689–695.
[41] K.J. Grande-Allen, N. Osman, M.L. Ballinger, H. Dadlani, S. Marasco, P.J. Little,
Glycosaminoglycan synthesis and structure as targets for the prevention of
calciﬁc aortic valve disease, Cardiovasc. Res. 76 (2007) 19–28.
[42] H.A. Barnes, J.F. Hutton, K. Walters, An Introduction to Rheology, Elsevier,
Amsterdam, 1989.
[43] A. Majzik, E. Tombácz, Interaction between humic acid and montmorillonite in
the presence of calcium ions II. Colloidal interactions: Charge state, dispersing
and/or aggregation of particles in suspension, Org. Geochem. 38 (2007)
1330–1340.
[44] J.M. Bigham, R.W. Fritzpatrick, D.G. Schulze, in: J.B. Dixon, D.G. Schulze (Eds.),
Soil Mineralogy with Environmental Applications, SSSA, Madison, 2002.
[45] E. Tombácz, Adsorption from Electrolyte Solutions, in: J. Tóth (Ed.), Adsorp-
tion: Theory, Modeling and Analysis, Marcel Dekker, New York, 2002.
[46] G. Sposito, Characterization of Particle Surface Charge, in: J. Bufﬂe, H.P. van
Leeuwen (Eds.), Environmental Particles, Lewis, Boca Raton, 1992.
[47] A. Einstein, Eine neue Bestimmung der Moleküldimensionen, Annalen der
Physik 19 (1906) 289–306.
[48] E.A. Balazs, The physical properties of synovial ﬂuid and the special role of
hyaluronic acid, in: A. Helfet (Ed.), Disorders of the knee, T.B. Lippincott
Company, Philadelphia, 1974.
[49] M.K. Cowman, S. Matsuoka, Experimental approaches to hyaluronan structure,
Carbohydr. Res. 340 (2005) 791–809.
[50] Sz Berkó, M. Maroda, M. Bodnár, G. Erős, P. Hartmann, K. Szentner, P. Szabó-
Révész, L. Kemény, J. Borbély, E. Csányi, Advantages of cross-linked versus
linear hyaluronic acid for semisolid skin delivery systems, Eur. Polym. J. 49
(2013) 511–2517.
[51] P. Mathieu, T. Conrozier, E. Vignon, Y. Rozand, M. Rinaudo, Rheologic behavior
of osteoarthritic synovial ﬂuid after addition of hyaluronic acid, Clin Orthop
Relat Res 467 (2009) 3002–3009.
